SCHEMBL683602

SCHEMBL683602

CCOc1ccc(C(C)C)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.67
TDP1 Q9NUW8 2/20 0.60
TSHR P16473 1/20 0.60
MAPT P10636 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MAPK1 P28482 1/20 0.53
LTA4H P09960 2/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ACACB O00763 4/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
NPBWR1 P48145 1/20 0.47
MCHR1 Q99705 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ACACA Q13085 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28529548 0.96 NQO1 (0.61) NQO1TDP1TSHRMAPTL3MBTL1
SCHEMBL2692130 0.94 NQO1 (0.58) NQO1TDP1TSHRMAPTL3MBTL1
SCHEMBL12203937 0.86 NQO1 (0.67) NQO1TDP1TSHRLTA4HACACB
SCHEMBL23236719 0.85 NQO1 (0.46) NQO1TDP1TSHRMAPTL3MBTL1
SCHEMBL2490798 0.83 NQO1 (0.70) NQO1TDP1TSHRMAPTL3MBTL1
SCHEMBL824979 0.83 NQO1 (0.70) NQO1TDP1TSHRMAPTL3MBTL1
SCHEMBL10824702 0.83 KMT2A (0.59) TDP1MEN1KMT2ARXRARXRB
Benzyl Alcohol SCHEMBL28300717 0.82 CNR2 (0.54) NQO1TDP1TSHRMAPTL3MBTL1
SCHEMBL7638085 0.82 NPC1 (0.58) MAPTMEN1KMT2AACACBRXRA
SCHEMBL17767220 0.82 NQO1 (0.61) NQO1TDP1TSHRLTA4HACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4035647-B1 TWO-COMPONENT SELF-ADHESIVE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-10-18 EP claimed
EP-4035647-A1 TWO-COMPONENT SELF-ADHESIVE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF 3M Innovative Properties Company (US) 2022-08-03 EP claimed
EP-4514304-B1 DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-03-25 EP disclosed
US-12577340-B2 Storage stable two-component dual cure dental composition SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-03-17 US disclosed
EP-4629958-A1 SURFACE-TREATED FILLER, DENTAL COMPOSITION CONTAINING SUCH A FILLER, PROCESS OF PRODUCTION AND USE THEREOF Solventum Intellectual Properties Company (US) 2025-10-15 EP disclosed
US-12440426-B2 Dental product with reduced extrusion forces SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-10-14 US disclosed
EP-4329704-B1 INITIATOR SYSTEM WITH POLYMERIZABLE THIOUREA COMPONENT, DENTAL COMPOSITION AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-10-08 EP disclosed
EP-3880156-B1 STORAGE STABLE TWO-COMPONENT DUAL CURE DENTAL COMPOSITION SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-08-20 EP disclosed
US-20250255785-A1 Dental Product with Reduced Extrusion Forces SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2025-08-14 US disclosed
EP-4175584-B1 PROCESS FOR PRODUCING A SURFACE-MODIFIED DENTAL ARTICLE SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2025-07-30 EP disclosed
EP-4586988-A1 DENTAL PRODUCT WITH REDUCED EXTRUSION FORCES Solventum Intellectual Properties Company (US) 2025-07-23 EP disclosed
WO-2006097534-A1 1,3-DIHYDRO-BENZIMIDAZOL-2-YLIDENE AMINES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD (IE) 2006-09-21 WO disclosed
CN-1688936-A Planar inorganic device 3M INNOVATIVE PROPERTIES CO (US) 2005-10-26 CN disclosed
WO-2005085161-A1 METHOD FOR PRODUCING AROMATIC ALKOXY KETONES Rütgers Chemicals AG (DE) 2005-09-15 WO disclosed
WO-2005009392-A2 DIHYDROPYRIMIDONE INHIBITORS OF CALCIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-03 WO disclosed
WO-2004002483-A1 SUBSTITUTED 3- AND 4- AMINOMETHYLPIPERIDINES FOR USE AS BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER’S DISEASE ACTELION PHARMACEUTICALS LTD (CH) 2004-01-08 WO disclosed
EP-0726921-B1 ENERGY-CURABLE CYANATE/ETHYLENICALLY UNSATURATED COMPOSITIONS MINNESOTA MINING & MFG (US) 2000-01-12 EP disclosed
EP-0957116-A2 Energy-curable ethylenically unsaturated compositions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-11-17 EP disclosed
EP-0521112-B1 POLYMERIC MIXTURES AND PROCESS THEREFOR MINNESOTA MINING & MFG (US) 1996-01-03 EP disclosed
CN-85107643-A The preparation method of the dibenzyl ether compound that replaces and as the purposes of agricultural chemicals 1986-08-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577340-B2 Storage stable two-component dual cure dental composition GPX4, SSRP1, H1-0 NQO1 1757/4885TDP1 1475/4885TSHR 3141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.